Close Menu

NEW YORK – Boston-based NanoView Biosciences said today that it has signed an exclusive agreement with Alfatest, headquartered in Rome, to distribute its ExoView platform in Italy.

The research-use-only ExoView platform is an antibody labeling and imaging-based extracellular vesicle detection system that provides size analysis, vesicle count, phenotyping, and biomarker colocalization. According to the company, it requires minimal sample input, no sample prep or purification, and can be used directly with complex biological samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US. 

A bipartisan group of senators has introduced a bill seeking increased funding for certain fields, including synthetic biology, ScienceInsider reports. 

Discover magazine writes that paleoproteomics is increasing being used in archaeology, paleoanthropology, and paleontology, including a recent study of a 6,000-year-old ring. 

In Nucleic Acids Research this week: mutagenic effects of ultraviolet "A" light, post-transcription effects of synonymous mutations, and more.